aromasil has been researched along with Neoplasm Metastasis, Unknown Primary in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Limmer, A; Robare, S; Swali, R | 1 |
| Bliss, JM; Coombes, RC; Fallowfield, LJ; Kilburn, LS; Langridge, C; Snowdon, CF | 1 |
1 trial(s) available for aromasil and Neoplasm Metastasis, Unknown Primary
| Article | Year |
|---|---|
Long-term assessment of quality of life in the Intergroup Exemestane Study: 5 years post-randomisation.
Topics: Androstadienes; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials, Phase III as Topic; Drug Substitution; Female; Follow-Up Studies; Humans; Libido; Neoplasms, Unknown Primary; Postmenopause; Quality of Life; Receptors, Estrogen; Surveys and Questionnaires; Tamoxifen; Treatment Outcome; Vaginal Discharge | 2012 |
1 other study(ies) available for aromasil and Neoplasm Metastasis, Unknown Primary
| Article | Year |
|---|---|
Multiple Pigmented Lesions of the Breast Following Ipsilateral Breast Carcinoma.
Topics: Aged; Androstadienes; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Breast Neoplasms; Carbamates; Female; Humans; Mastectomy; Mastectomy, Segmental; Melanoma; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Neoplasms, Unknown Primary; Radiotherapy; Skin Neoplasms; Sulfonamides | 2020 |